Clinical Trials Browser

Phase 1/2 × Liver Diseases × 1 year × Clear all

NCT07053488 2025-07-08

CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection

Phase 1/2 Recruiting

Gastrointestinal

Fatty Liver, Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Liver Failure